Literature DB >> 29313189

Supportive properties of basement membrane layer of human amniotic membrane enable development of tissue engineering applications.

Sonia Iranpour1, Nasser Mahdavi-Shahri1, Raheleh Miri2, Halimeh Hasanzadeh3, Hamid Reza Bidkhori3, Hojjat Naderi-Meshkin3, Ehsan Zahabi4, Maryam M Matin5,6,7.   

Abstract

Human amniotic membrane (HAM) has been widely used as a natural scaffold in tissue engineering due to many of its unique biological properties such as providing growth factors, cytokines and tissue inhibitors of metalloproteinases. This study aimed at finding the most suitable and supportive layer of HAM as a delivery system for autologous or allogeneic cell transplantation. Three different layers of HAM were examined including basement membrane, epithelial and stromal layers. In order to prepare the basement membrane, de-epithelialization was performed using 0.5 M NaOH and its efficiency was investigated by histological stainings, DNA quantification, biomechanical testing and electron microscopy. Adipose-derived stromal cells (ASCs) and a human immortalized keratinocyte cell line (HaCaT) were seeded on the three different layers of HAM and cultured for 3 weeks. The potential of the three different layers of HAM to support the attachment and viability of cells were then monitored by histology, electron microscopy and (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Moreover, mechanical strengths of the basement membrane were assessed before and after cell culture. The results indicated that the integrity of extra cellular matrix (ECM) components was preserved after de-epithelialization and resulted in producing an intact basement amniotic membrane (BAM). Moreover, all three layers of HAM could support the attachment and proliferation of cells with no visible cytotoxic effects. However, the growth and viability of both cell types on the BAM were significantly higher than the other two layers. We conclude that growth stimulating effectors of BAM and its increased mechanical strength after culturing of ASCs, besides lack of immunogenicity make it an ideal model for delivering allogeneic cells and tissue engineering applications.

Entities:  

Keywords:  Adipose-derived stromal cells and HaCaT cells; Amniotic membrane; Scaffold; Tissue engineering

Mesh:

Substances:

Year:  2018        PMID: 29313189     DOI: 10.1007/s10561-017-9680-z

Source DB:  PubMed          Journal:  Cell Tissue Bank        ISSN: 1389-9333            Impact factor:   1.522


  5 in total

1.  Case Report: Wound Closure Acceleration in a Patient With Toxic Epidermal Necrolysis Using a Lyophilised Amniotic Membrane.

Authors:  Bretislav Lipový; Martin Hladík; Petr Štourač; Serhiy Forostyak
Journal:  Front Bioeng Biotechnol       Date:  2021-04-16

2.  Kidney tissue engineering using a well-preserved acellular rat kidney scaffold and mesenchymal stem cells.

Authors:  Samira Shahraki; Maryam Moghaddam Matin; Alireza Ebrahimzadeh Bideskan; Mohammad Aslzare; Ahmad Reza Bahrami; Sara Hosseinian; Sonia Iranpour; Zahra Samadi Noshahr; Abolfazl Khajavi Rad
Journal:  Vet Res Forum       Date:  2021-09-15       Impact factor: 0.950

3.  Case Report: Freeze-Dried Human Amniotic Membrane Allograft for the Treatment of Chronic Wounds: Results of a Multicentre Observational Study.

Authors:  Iveta Schmiedova; Zuzana Ozanova; Elen Stastna; Ludmila Kiselakova; Bretislav Lipovy; Serhiy Forostyak
Journal:  Front Bioeng Biotechnol       Date:  2021-06-24

Review 4.  Applications of Human Amniotic Membrane for Tissue Engineering.

Authors:  Mathilde Fénelon; Sylvain Catros; Christophe Meyer; Jean-Christophe Fricain; Laurent Obert; Frédéric Auber; Aurélien Louvrier; Florelle Gindraux
Journal:  Membranes (Basel)       Date:  2021-05-25

5.  Successful Regenerative Endodontic Procedure of a Nonvital Immature Permanent Central Incisor Using Amniotic Membrane as a Novel Scaffold.

Authors:  Nandini Suresh; Buvaneshwari Arul; Dinesh Kowsky; Velmurugan Natanasabapathy
Journal:  Dent J (Basel)       Date:  2018-08-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.